2013

1. Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: A phase III trial of the AGO OVAR, COGI, GINECO, and GEICO-the MIMOSA study

   Journal of Clinical Oncology, Vol. 31, Núm. 12, pp. 1554-1561

2. Randomized, phase II, placebo-controlled, double-blind study with and without enzastaurin in combination with paclitaxel and carboplatin as first-line treatment followed by maintenance treatment in advanced ovarian cancer

   Journal of Clinical Oncology, Vol. 31, Núm. 25, pp. 3127-3132